advertisement

Topcon

Journal of Ocular Pharmacology and Therapeutics 6

Showing records 1 to 6 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

24420 Cytochrome oxidase 2D6 gene polymorphism in primary open-angle glaucoma with various effects to ophthalmic timolol
Yang Y; Wu K; Yuan H; Yu M
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 163-171
24418 Acetazolamide influences ocular pulse amplitude
Zinkernagel MS; Ebneter A
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 141-144
24344 A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar Hemodynamics and Intraocular Pressure in Open-Angle Glaucoma Patients
Martinez A; Sanchez-Salorio M
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 239-248
24341 Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma
Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 259-263
24421 The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence
Zimmerman TJ; Hahn SR; Gelb L; Tan H; Kim EE
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 145-152
24343 Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits
Arnold JJ; Choksi Y; Chen X; Shimazaki A; Hatten J; Toone EJ; Epstein DL; Challa P
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 179-186

Issue 11-3

Change Issue


advertisement

Oculus